Recent

% | $
Quotes you view appear here for quick access.

IntelliPharmaCeutics International Inc. Message Board

  • chainma1l chainma1l Jan 7, 2013 9:25 AM Flag

    LMAO!

    I was wondering why any company would be stupid enough to pay 12% on anything, but since it's going right into Odidididdi's pocket, I guess that's just par for the course with IPCI.
    This "company" is a scam. Stay away.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • People who research this company can see the Truth / Facts & how the share holders get treated by this Nigerian crew of worthless directors !!! The competition is already SELLING the drugs IPCI had wanted. Focalin is already under control of Novartis & the patent does not expire till 2015 !!! IPCI won't be able to SELL ANY Focalin till 2015 !!! Novartis has the ability to file for a patent extension which would further delay any competition to its Patent. Bills are piling up with this new $1.5 Million financing the "Private Deal Beneficiaries" have the option to take 12 % interest or SELL IPCI stock at $3.00 / share. Guess who will be paying for this too ? That is right Share Holders, it will be you once again !!!

      Sentiment: Strong Sell

    • LMAO at you... Apparently you know nothing about financing in the small bio-tech world... if you did... you would realize what an excellent deal this minor-dilutive financing is for the company.

    • People who research this company can see the Truth / Facts & how the share holders get treated by this Nigerian crew of worthless directors !!! The competition is already SELLING the drugs IPCI had wanted. Focalin is already under control of Novartis & the patent does not expire till 2015 !!! IPCI won't be able to SELL ANY Focalin till 2015 !!! Novartis has the ability to file for a patent extension which would further delay any competition to its Patent. Bills are piling up with this new $1.5 Million financing the "Private Deal Beneficiaries" have the option to take 12 % interest or SELL IPCI stock at $3.00 / share. Guess who will be paying for this too ? That is right Share Holders, it will be you once again !!!

      Sentiment: Strong Sell

    • Odidi is funding IPCI (again) from his own resources rather than immediately dilute the stock with another offering. That may be interpreted to mean 1) He is putting his money where his mouth is, 2) he is sensitive to dilutative financing, 3) he reckons $1.5M is enough working capital to bridge IPCI until FDA approval, and 4) he is confident of FDA approval. His participation may also mean additional revenue from 1) Par mileston payment upon approval and 2) pending partnerships upon approval. I had hoped the market would've reacted more favorably. That it did not might help confirm my suspicion that IPCI is under accumulation through the manipulation by the market makers. Large buy orders haven't been moving the price over the last several months and small sell orders seem to tank the price. I don't know who is selling other than previous convertible holders.

      Despite the low quality of posts on this board vilifying Odidi, he has kept the company producing as an on-going concern with 8 ANDAs and a clinical trial of pregabalin. All ANDAs were accepted by the FDA on the initial submission. The ball is in the FDA's court, something Odidi has no control. Eventually, the FDA must rule, albeit much later than is currently required by law for ANDA review times.

      Protonix and Metaformin were accepted by the FDA about 10 months after Focalin patent issues were resolved. Who knows when the FDA will rule on any generic but you can add 10 months to the Focalin date to arrive at an estimate for the latter drugs.

    • I'm surprised its Only 12% !!! And what is with keeping it "Private" ? Is this the way to Pay supporters who write articles claiming how great IPCI is as a company ? This Nigerian crew is something else !!! What is next ?

      Sentiment: Strong Sell

 
IPCI
1.92+0.05(+2.67%)Aug 23 3:59 PMEDT